Table 2 Participants' clinical characteristics based on available laboratory readings stratified by year
From: Prevalence of chronic kidney disease in Saudi Arabia: an epidemiological population-based study
Measurement (mean (SD)) | Entire cohort | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|
Serum creatinine mg/dL) | 0.81 (0.54) | 0.83 (0.51) | 0.84 (0.58) | 0.82 (0.57) | 0.83 (0.54) | 0.82 (0.56) | 0.82 (0.59) | 0.79 (0.51) | 0.79 (0.5) |
Mean eGFR/EPI (ml/min/1.73 m2) | 88 (26.98) | 96.93 (24.02) | 94.88 (24.68) | 89.21 (26.26) | 81.1 (25.35) | 80.88 (26.63) | 73.42 (25.04) | 83.15 (28.41) | 97.07 (26.49) |
Body mass index (BMI) (Kg/m2) | 29.25 (5.86) | 28.87 (5.18) | 28.86 (5.52) | 28.95 (5.84) | 29.21 (5.99) | 29.3 (6.07) | 29.47 (6.14) | 29.65 (5.94) | 29.67 (5.55) |
LDL-C (mg/dL) | 129.80 (37.1) | 128.76 (37.89) | 127.48 (37.84) | 127.03 (37.94) | 129.45 (37.87) | 132.63 (37.93) | 131.12 (37.85) | 130.77 (37.47) | 132.03 (37.87) |
HDL-C (mg/dL) | 50.25 (12.87) | 50.45 (12.71) | 51.05 (12.91) | 51.34 (13.04) | 50.08 (12.57) | 50.01 (12.63) | 49.44 (12.64) | 49.21 (12.72) | 49.45 (12.77) |
Triglyceride (mg/dL) | 116.91 (67.24) | 114.32 (79.12) | 114.1 (73.58) | 116.04 (71.23) | 116.46 (69.97) | 117.21 (73.79) | 118.08 (75.72) | 119.21 (80) | 121.66 (91.74) |
HbA1c (%) | 5.79 (1.32) | 5.7 (1.26) | 5.76 (1.28) | 5.82 (1.35) | 5.81 (1.32) | 5.81 (1.34) | 5.81 (1.35) | 5.86 (1.38) | 5.91 (1.38) |
Systolic Blood pressure (mmHg) | 124.34 (23.10) | 124.28 (21.64) | 124.3 (21.81) | 124.8 (20.05) | 124.93 (20.09) | 124.78 (21.9) | 124.22 (25.38) | 123.27 (27.46) | 123.75 (27.16) |
Diastolic Blood pressure (mmHg) | 76.86 (13.25) | 77.66 (11.8) | 77.45 (11.62) | 77.77 (11.57) | 77.54 (11.59) | 77.18 (13.24) | 76.03 (14.21) | 75.25 (16.29) | 75.47 (15.3)al |